(Q34891196)

5 August 2017

1 reference

title

BCL-2 family antagonists for cancer therapy (English)

1 reference

5 August 2017

Guillaume Lessene

1

1 reference

5 August 2017

Peter E Czabotar

series ordinal

2

1 reference

5 August 2017

Peter M Colman

series ordinal

3

1 reference

5 August 2017

publication date

1 December 2008

1 reference

Nature Reviews Drug Discovery

5 August 2017

published in

1 reference

5 August 2017

volume

7

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

989-1000

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd2658

5 August 2017

exact match

0 references

cites work

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

31 March 2020

The Hallmarks of Cancer

1 reference

The Bcl-2 apoptotic switch in cancer development and therapy

31 March 2020

1 reference

The BCL-2 protein family: opposing activities that mediate cell death

31 March 2020

1 reference

Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands

31 March 2020

1 reference

BH3-Only proteins-essential initiators of apoptotic cell death

31 March 2020

1 reference

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

31 March 2020

1 reference

Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis

31 March 2020

1 reference

Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak

31 March 2020

1 reference

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

31 March 2020

1 reference

BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly

31 March 2020

1 reference

The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues

31 March 2020

1 reference

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

31 March 2020

1 reference

Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes

31 March 2020

1 reference

Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein

31 March 2020

1 reference

Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1

31 March 2020

1 reference

Autophagy in the Pathogenesis of Disease

31 March 2020

1 reference

31 March 2020

1 reference

Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice

31 March 2020

1 reference

Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair

31 March 2020

1 reference

Testicular degeneration in Bclw-deficient mice

31 March 2020

1 reference

Programmed anuclear cell death delimits platelet life span.

31 March 2020

1 reference

Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function

31 March 2020

1 reference

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

31 March 2020

1 reference

PUMA, a novel proapoptotic gene, is induced by p53

31 March 2020

1 reference

The role of BH3-only proteins in the immune system

31 March 2020

1 reference

ER stress triggers apoptosis by activating BH3-only protein Bim

31 March 2020

1 reference

Promoting apoptosis as a strategy for cancer drug discovery

31 March 2020

1 reference

Unique biology of Mcl-1: therapeutic opportunities in cancer

31 March 2020

1 reference

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

31 March 2020

1 reference

A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival.

31 March 2020

1 reference

Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins

31 March 2020

1 reference

A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation

31 March 2020

1 reference

Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies

31 March 2020

1 reference

Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix

31 March 2020

1 reference

A stapled BID BH3 helix directly binds and activates BAX

31 March 2020

1 reference

(alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions

31 March 2020

1 reference

Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry

31 March 2020

1 reference

Synthesis of a 2,3';6',3''-terpyridine scaffold as an alpha-helix mimetic

31 March 2020

1 reference

Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein

31 March 2020

1 reference

Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

31 March 2020

1 reference

Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells

31 March 2020

1 reference

Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening

31 March 2020

1 reference

Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3.

31 March 2020

1 reference

Identification of chelerythrine as an inhibitor of BclXL function

31 March 2020

1 reference

Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins

31 March 2020

1 reference

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

31 March 2020

1 reference

Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs

31 March 2020

1 reference

The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak

31 March 2020

1 reference

Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins

31 March 2020

1 reference

Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities

31 March 2020

1 reference

Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

31 March 2020

1 reference

A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells

31 March 2020

1 reference

Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition with U0126, rapamycin and Bcl-2 inhibitor GX15-070

31 March 2020

1 reference

Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax).

31 March 2020

1 reference

ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor

31 March 2020

1 reference

Investigations on gossypol: past and present developments

31 March 2020

1 reference

Different pathways of cell killing by gossypol enantiomers.

31 March 2020

1 reference

Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins.

31 March 2020

1 reference

Aminoglycoside suppression of nonsense mutations in severe hemophilia

31 March 2020

1 reference

Gossypol induces Bax/Bak-independent activation of apoptosis and cytochrome c release via a conformational change in Bcl-2

31 March 2020

1 reference

Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins

31 March 2020

1 reference

Structure-based design of flavonoid compounds as a new class of small-molecule inhibitors of the anti-apoptotic Bcl-2 proteins.

31 March 2020

1 reference

A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species.

31 March 2020

1 reference

Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2

31 March 2020

1 reference

Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model

31 March 2020

1 reference

Target-oriented and diversity-oriented organic synthesis in drug discovery

31 March 2020

1 reference

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

31 March 2020

1 reference

Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis

31 March 2020

1 reference

Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivo

31 March 2020

1 reference

A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo

31 March 2020

1 reference

Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL

31 March 2020

1 reference

Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family

31 March 2020

1 reference

Molecular properties that influence the oral bioavailability of drug candidates

31 March 2020

1 reference

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

31 March 2020

1 reference

ABT-737, proving to be a great tool even before it is proven in the clinic

31 March 2020

1 reference

Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation

31 March 2020

1 reference

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

31 March 2020

1 reference

Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

31 March 2020

1 reference

'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737.

31 March 2020

1 reference

A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells.

31 March 2020

1 reference

ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells.

31 March 2020

1 reference

Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing program

31 March 2020

1 reference

Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models

31 March 2020

1 reference

Bcl-2 family proteins are essential for platelet survival.

31 March 2020

1 reference

BH3-only proteins in cell death initiation, malignant disease and anticancer therapy.

31 March 2020

1 reference

Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.

31 March 2020

1 reference

Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim.

31 March 2020

1 reference

EGL-1 BH3 mutants reveal the importance of protein levels and target affinity for cell-killing potency.

31 March 2020

1 reference

Strategies for targeting protein-protein interactions with synthetic agents.

31 March 2020

1 reference

Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets

31 March 2020

1 reference

Solution structure of BID, an intracellular amplifier of apoptotic signaling

31 March 2020

1 reference

Regulation of apoptosis: uncovering the binding determinants

31 March 2020

1 reference

Structural biology of the Bcl-2 family of proteins

31 March 2020

1 reference

Structural plasticity underpins promiscuous binding of the prosurvival protein A1

31 March 2020

1 reference

Structural insights into the degradation of Mcl-1 induced by BH3 domains

31 March 2020

1 reference

The structure of a Bcl-xL/Bim fragment complex: implications for Bim function

31 March 2020

1 reference

Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands.

31 March 2020

1 reference

31 March 2020

The Protein Data Bank

1 reference

Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD2658

1 reference

5 August 2017

1 reference